Stokes Frank bought CSTL

March 4, 2026 · Form 4 insider transaction

Stokes Frank bought 3,800 shares of Castle Biosciences, Inc. at $3.38 per share, a transaction worth $12.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.